ED is a global issue affecting millions of men, but often goes left untreated. It has several causes: behavioral – such as high levels of stress, alcohol consumption, smoking, and nutrition; psychological – such as anxiety, depression or mental health issues; and physiological conditions – such as heart disease, high cholesterol, diabetes and aging, which can impair vascular function. This is where Alma Duo can help.
Raul I Clavijo et al.
The Journal of Sexual Medicine, 2017
Jeffrey D. Campbell et al.
Therapeutic Advances in Urology, 2019
Ioannis Sokolakis, Georgios Hatzichristodoulou
International Journal of Impotence Research, 2019
Sexual wellness is one of the fastest growing segments in aesthetic practice, and Alma Duo is a purpose-built platform for it rather than an adapted skin device. It treats male erectile function using low-intensity acoustic shockwave. For a clinic the appeal is a discreet, non-surgical, no-downtime treatment sold as a course, delivered by trained staff in a standard consulting room, that reaches a patient group most aesthetic clinics never see. Talk to an Alma representative about scope of practice and which clinicians in your state can deliver these treatments.
Alma Duo uses low-intensity acoustic shockwaves rather than laser. A handpiece delivers pulses of acoustic energy into the target tissue, which triggers the body’s own repair response and encourages the formation of new microvasculature. Because erectile function depends heavily on blood flow, improving that vascular supply is the mechanism the treatment relies on. Sessions are performed in the clinic, take around fifteen minutes, need no anaesthetic and no downtime, and a course is normally six sessions over a few weeks.
Alma Duo is backed up with clinical studies and publications, and is FDA and CE approved.
This will depend on the severity of the ED, but often as few as six treatments, over a three-week period will be sufficient for an improvement in erectile dysfunction scores.
Alma’s solution for treating erectile dysfunction uses low-intensity extracorporeal shock wave therapy (LI-ESWT).
